Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2019 | Phase III trial: chemotherapy plus local-regional radiotherapy in pmNPCC

Ming-Yuan Chen, MD, PhD, Sun Yat-Sen University Cancer Center, Guangzhou, China, outlines the key findings from the Phase III trial regarding chemotherapy plus local-regional radiotherapy versus chemotherapy alone in primary metastatic nasopharyngeal carcinoma (NPC). This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.